This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thermo Fisher Scientific Inc (TMO)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 1.89B 1.27B 1.18B 1.02B
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -145.40M -147.90M 12.00M -107.30M
(Increase) Decrease in Inventories -109.80M -72.20M -59.90M -32.50M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 1.20M 47.00M 10.00M 31.40M
(Decrease) Increase In Other Current Liabilities 308.40M 163.30M 127.20M 0.00
(Increase) Decrease In Other Working Capital 113.50M 130.50M -123.60M -156.50M
Other Non-Cash Items -501.40M 94.50M 242.20M 183.30M
Net Cash From Continuing Operations 2.62B 2.02B 2.07B 1.68B
Net Cash From Discontinued Operations -4.30M -4.90M -28.40M 12.60M
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 2.62B 2.01B 2.04B 1.69B
Sale of Property, Plant & Equipment 49.30M 20.70M 12.80M 8.20M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -427.60M -282.40M -315.10M -266.50M
Acquisitions -11.54B -11.40M -1.08B -5.68B
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 45.30M 2.20M -800.00K -6.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -11.78B -263.30M -1.33B -5.14B
Issuance of Debt 6.59B 0.00 1.28B 4.25B
Cash Used for Financing Activities
Issuance of Capital Stock 3.10B 0.00 254.10M 158.10M
Repayment of Long-Term Debt -4.43B -1.00M -354.50M -453.40M
Repurchase of Capital Stock 0.00 -89.80M -1.15B -1.34B
Payment of Cash Dividends -234.80M -216.20M -142.20M 0.00
Other Financing Charges, Net -229.40M 3.62B -807.20M 929.30M
Net Cash From Financing Activities 4.80B 3.31B -917.70M 3.55B
Effect of Exchange Rate Changes -115.50M -37.00M 38.70M -200.00K
Net Change in Cash & Cash Equivalents -4.48B 5.02B -165.30M 99.20M
TMO News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

TMO Thermo Fisher Scientific Inc

Chart of TMO

Analysts Ratings for TMO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 14 14 13 13
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

TMO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs